Celldex Therapeutics, Inc. Logo

Celldex Therapeutics, Inc.

Develops antibody-based immunotherapies for severe inflammatory and allergic diseases.

CLDX | US

Overview

Corporate Details

ISIN(s):
US15117B2025
LEI:
Country:
United States of America
Address:
53 FRONTAGE ROAD, 8827 HAMPTON

Description

Celldex Therapeutics is a clinical-stage biopharmaceutical company that develops antibody-based immunotherapies. The company's research focuses on the intersection of mast cell biology and immunology to treat severe inflammatory, allergic, and autoimmune diseases. Its lead program is barzolvolimab, a humanized monoclonal antibody that inhibits KIT, a receptor tyrosine kinase essential for the function and survival of mast cells. By targeting this core pathological driver, Celldex aims to provide a best-in-class treatment option. The company leverages proprietary antibody programs and technologies supported by in-house discovery and development capabilities to advance its pipeline.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-04 22:04 English 7.1 KB
2025-11-17 22:17 English 8.3 KB
2025-11-15 01:58 English 9.0 KB
2025-11-14 23:08 English 10.6 KB
2025-11-14 18:19 English 8.6 KB
2025-11-13 22:15 English 7.1 KB
2025-11-12 22:12 English 7.4 KB
2025-11-12 22:05 English 9.5 KB
2025-11-10 22:06
10-Q
English 1.3 MB
2025-11-10 22:01
FORM 8-K
English 102.0 KB
2025-11-07 14:18 English 12.0 KB
2025-08-19 22:04
FORM 8-K
English 105.5 KB
2025-08-15 22:07 English 7.0 KB
2025-08-14 20:59 English 10.0 KB
2025-08-12 16:34 English 12.0 KB

Automate Your Workflow. Get a real-time feed of all Celldex Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Celldex Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Celldex Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aldeyra Therapeutics, Inc. Logo
Develops medications for immune-mediated ocular and systemic diseases.
United States of America
ALDX
Alector, Inc. Logo
Clinical-stage biotech using immuno-neurology to treat neurodegenerative diseases.
United States of America
ALEC
ALK-Abelló Logo
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
Denmark
ALK
Alkaloid AD Logo
Manufactures generic pharmaceuticals, cosmetics, and chemical products.
North Macedonia
ALK
Alkermes plc. Logo
Develops and commercializes medicines for central nervous system (CNS) diseases.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
A clinical-stage biopharma using diagnostics to develop targeted cancer therapies.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Immunology company developing aluminum-free vaccines and therapies for allergies.
United Kingdom
AGY
Alligator Bioscience Logo
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Develops off-the-shelf allogeneic CAR T therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
Global biopharmaceutical company specializing in medical dermatology and skin health.
Spain
ALM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.